Overexpression of the IGF2-mRNA binding protein p62 in transgenic mice induces a steatotic phenotype

Journal of Hepatology

Volumn 54, Issue 5, 2011, Pages 994-1001

  Tybl, Elisabeth ^a   Shi, Fu Dong ^b   Kessler, Sonja M ^a   Tierling, Sascha ^a   Walter, Jörn ^a   Bohle, Rainer M ^c   Wieland, Stefan ^d   Zhang, Jianying ^e   Tan, Eng M ^d   Kiemer, Alexandra K ^a  

^a SAARLAND UNIVERSITY   (Germany)

^b BARROW NEUROLOGICAL INSTITUTE   (United States)

^c SAARLAND UNIVERSITY   (Germany)

^d SCRIPPS RESEARCH INSTITUTE   (United States)

^e UNIVERSITY OF TEXAS AT EL PASO   (United States)

Author keywords

CMV promoter activity; IMP; NAFLD; NASH; p65; PTEN

Indexed keywords

AUTOIMMUNE REGULATOR PROTEIN; MESSENGER RNA; PROTEIN P62; RNA H19; SOMATOMEDIN B;

ALLELE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; FATTY LIVER; GENE EXPRESSION; GENE OVEREXPRESSION; GLUCOSE TOLERANCE; LIVER INJURY; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

ANIMALS; FATTY LIVER; GENE EXPRESSION; GLUCOSE INTOLERANCE; HUMANS; INSULIN-LIKE GROWTH FACTOR II; LIVER; MICE; MICE, TRANSGENIC; PHENOTYPE; PROMOTER REGIONS, GENETIC; RNA, MESSENGER; TRANSCRIPTION FACTORS;

EID: 79954648698     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2010.08.034     Document Type: Article

References (49)

1. S. Takamatsu, N. Noguchi, A. Kudoh, N. Nakamura, T. Kawamura, and K. Teramoto Influence of risk factors for metabolic syndrome and non-alcoholic fatty liver disease on the progression and prognosis of hepatocellular carcinoma Hepatogastroenterology 55 2008 609 614 (Pubitemid 351741512)
2. J.Y. Zhang, E.K. Chan, X.X. Peng, and E.M. Tan A novel cytoplasmic protein with RNA-binding motifs is an autoantigen in human hepatocellular carcinoma J Exp Med 189 1999 1101 1110 (Pubitemid 29169827)
3. M. Lu, R.M. Nakamura, E.D. Dent, J.-Y. Zhang, F.C. Nielsen, and J. Christiansen Aberrant expression of fetal RNA-binding protein p62 in liver cancer and liver cirrhosis Am J Pathol 159 2001 945 953 (Pubitemid 32847185)
4. Y.M. Jeng, C.C. Chang, F.C. Hu, H.Y. Chou, H.L. Kao, and T.H. Wang RNA-binding protein insulin-like growth factor II mRNA-binding protein 3 expression promotes tumor invasion and predicts early recurrence and poor prognosis in hepatocellular carcinoma Hepatology 48 2008 1118 1127
5. T.V. Hansen, N.A. Hammer, J. Nielsen, M. Madsen, C. Dalbaeck, and U.M. Wewer Dwarfism and impaired gut development in insulin-like growth factor II mRNA-binding protein 1-deficient mice Mol Cell Biol 24 2004 4448 4464 (Pubitemid 41071014)
6. L. Hutchinson Medical oncology: IMP3 is a novel prognostic marker for colon cancer Nat Rev Clin Oncol 7 2010 123
7. X. Yao, J.F. Hu, M. Daniels, H. Shiran, X. Zhou, and H. Yan A methylated oligonucleotide inhibtis IGF2 expression and enhances survival in a model of hepatocellaular carcinoma J Clin Invest 111 2003 265 273 (Pubitemid 36105926)
8. W.J. Saho, L.Y. Tao, C. Gao, J.Y. Xie, and R.Q. Zhao Alterations in methylation and expression levels of imprinted genes H19 and Igf2 in the fetuses of diabetic mice Comp Med 58 2008 341 346
9. F.C. Nielsen The molecular and cellular biology of insulin-like growth factor II Prog Growth Factor Res 4 1992 257 290
10. A. Suzuki, T. Nakano, T.W. Mak, and T. Sasaki Portrait of PTEN: messages from mutant mice Cancer Sci 99 2008 209 213 (Pubitemid 351232668)
11. M. Vinciguerra, A. Sgroi, C. Veyrat-Durebex, L. Rubbia-Brandt, L.H. Buhler, and M. Foti Unsaturated fatty acids inhibit the expression of tumor suppressor phosphatase and tensin homolog (PTEN) via microRNA-21 up-regulation in hepatocytes Hepatology 49 2009 1176 1184
12. A. Kistner, M. Gossen, F. Zimmermann, J. Jerecic, C. Ullmer, and H. Lubbert Doxycycline-mediated quantitative and tissue-specific control of gene expression in transgenic mice Proc Natl Acad Sci USA 93 1996 10933 10938 (Pubitemid 26333095)
13. T. Yoshimizu, A. Miroglio, M.A. Ripoche, A. Gabory, M. Vernucci, and A. Riccio The H19 locus acts in vivo as a tumor suppressor Proc Natl Acad Sci USA 105 2008 12417 12422
14. A.K. Kiemer, R.H. Senaratne, J. Hoppstädter, B. Diesel, L. Riley, and K. Tabeta Attenuated activation of macrophage TLR9 by DNA from virulent mycobacteria J Innate Immun 1 2009 29 45
15. J. Bouayed, F. Desor, H. Rammal, A.K. Kiemer, E. Tybl, and H. Schroeder Effects of lactational exposure to benzo[alpha]pyrene (B[alpha]P) on postnatal neurodevelopment, neuronal receptor gene expression and behaviour in mice Toxicology 259 2009 97 106
16. S. Tierling, S. Dalbert, S. Schoppenhorst, C.E. Tsai, S. Oliger, and A.C. Ferguson-Smith High-resolution map and imprinting analysis of the Gtl2-Dnchc1 domain on mouse chromosome 12 Genomics 87 2006 225 235 (Pubitemid 43117443)
17. S. Kulhanek-Heinze, A. Gerbes, T. Gerwig, A.M. Vollmar, and A.K. Kiemer Protein kinase A dependent signalling mediates anti-apoptotic effects of the atrial natriuretic peptide in ischemic livers J Hepatol 41 2004 414 420 (Pubitemid 39158750)
18. A.K. Kiemer, and A.M. Vollmar Autocrine Regulation of Inducible Nitric-oxide Synthase in Macrophages by Atrial Natriuretic Peptide J Biol Chem 273 1998 13444 13451 (Pubitemid 28268383)
19. F. Duenschede, E. Tybl, A.K. Kiemer, P. Dutkowski, K. Erbes, and A. Kircher Bcl-2 upregulation after 3-nitropropionic acid preconditioning in warm rat liver ischemia Shock 30 2008 699 704
20. H. Sasaki, K. Ishihara, and R. Kato Mechanisms of Igf2/H19 imprinting: DNA methylation, chromatin and long-distance gene regulation J Biochem 127 2000 711 715 (Pubitemid 30317892)
21. W. Eberhardt, A. Doller, E.-S. Akool, and J. Pfeilschifter Modulation of mRNA stability as a novel therapeutic approach Pharmacol Ther 114 2007 56 73 (Pubitemid 46498160)
22. J.B. Johnnidis, E.S. Venanzi, D.J. Taxman, J.P.Y. Ting, C.O. Benoist, and D.J. Mathis Chromosomal clustering of genes controlled by the aire transcription factor Proc Natl Acad Sci USA 102 2005 7233 7238 (Pubitemid 40696362)
23. Q. Su, A. Benner, W.J. Hofmann, G. Otto, R. Pichlmayr, and P. Bannasch Human hepatic preneoplasia: phenotypes and proliferation kinetics of foci and nodules of altered hepatocytes and their relationship to liver cell dysplasia Virchows Arch 431 1997 391 406 (Pubitemid 27519372)
24. B. Stiles, Y. Wang, A. Stahl, S. Bassilian, W.P. Lee, and Y.J. Kim Liver-specific deletion of negative regulator Pten results in fatty liver and insulin hypersensitivity Proc Natl Acad Sci USA 101 2004 2082 2087 (Pubitemid 38229018)
25. F. Chiappini, A. Barrier, R. Saffroy, M.C. Domart, N. Dagues, and D. Azoulay Exploration of global gene expression in human liver steatosis by high-density oligonucleotide microarray Lab Invest 86 2006 154 165 (Pubitemid 43117595)
26. M.R. Teli, O.F. James, A.D. Burt, M.K. Bennett, and C.P. Day The natural history of nonalcoholic fatty liver: a follow-up study Hepatology 22 1995 1714 1719
27. L. Lee, M. Alloosh, R. Saxena, W.V. Alstine, B.A. Watkins, and J.E. Klaunig Nutritional model of steatohepatitis and metabolic syndrome in the Ossabaw miniature swine Hepatology 50 2009 56 67
28. Z. Xu, L. Chen, L. Leung, T.S. Yen, C. Lee, and J.Y. Chan Liver-specific inactivation of the Nrf1 gene in adult mouse leads to nonalcoholic steatohepatitis and hepatic neoplasia Proc Natl Acad Sci USA 102 2005 4120 4125 (Pubitemid 40388565)
29. K. Otogawa, K. Kinoshita, H. Fujii, M. Sakabe, R. Shiga, and K. Nakatani Erythrophagocytosis by liver macrophages (Kupffer cells) promotes oxidative stress, inflammation, and fibrosis in a rabbit model of steatohepatitis: implications for the pathogenesis of human nonalcoholic steatohepatitis Am J Pathol 170 2007 967 980 (Pubitemid 47339365)
30. O.E. Owen, F.A. Reichle, M.A. Mozzoli, T. Kreulen, M.S. Patel, and I.B. Elfenbein Hepatic, gut, and renal substrate flux rates in patients with hepatic cirrhosis J Clin Invest 68 1981 240 252 (Pubitemid 11048096)
31. R. O'Connor Survival factors and apoptosis Adv Biochem Eng Biotechnol 62 1998 137 166
32. S. Hassler, C. Ramsey, M.C. Karlsson, D. Larsson, B. Herrmann, and B. Rozell Aire-deficient mice develop hematopoetic irregularities and marginal zone B-cell lymphoma Blood 108 2006 1941 1948 (Pubitemid 44395004)
33. C.M. Perks, E.G. Vernon, A.H. Rosendahl, D. Tonge, and J.M. Holly IGF-II and IGFBP-2 differentially regulate PTEN in human breast cancer cells Oncogene 26 2007 5966 5972
34. R.A. Moorehead, C.V. Hojilla, I. De Belle, G.A. Wood, J.E. Fata, and E.D. Adamson Insulin-like growth factor-II regulates PTEN expression in the mammary gland J Biol Chem 278 2003 50422 50427 (Pubitemid 37548886)
35. M. Vinciguerra, F. Carrozzino, M. Peyrou, S. Carlone, R. Montesano, and R. Benelli Unsaturated fatty acids promote hepatoma proliferation and progression through downregulation of the tumor suppressor PTEN J Hepatol 50 2009 1132 1141
36. R. Oerlemans, J. Vink, B.A.C. Dijkmans, Y.G. Assaraf, M. van Miltenburg, and J. van der Heijden Sulfasalazine sensitises human monocytic/macrophage cells for glucocorticoids by upregulation of glucocorticoid receptor and glucocorticoid induced apoptosis Ann Rheum Dis 66 2007 1289 1295 (Pubitemid 47492470)
37. M.P. Charalambous, T. Lightfoot, V. Speirs, K. Horgan, and N.J. Gooderham Expression of COX-2, NF-kappaB-p65, NF-kappaB-p50 and IKKalpha in malignant and adjacent normal human colorectal tissue Br J Cancer 101 2009 106 115
38. R. Visconti, J. Cerutti, S. Battista, M. Fedele, F. Trapasso, and K. Zeki Expression of the neoplastic phenotype by human thyroid carcinoma cell lines requires NFkappaB p65 protein expression Oncogene 15 1997 1987 1994
39. L. Gu, H.W. Findley, and M. Zhou MDM2 induces NF-kappaB/p65 expression transcriptionally through Sp1-binding sites: a novel, p53-independent role of MDM2 in doxorubicin resistance in acute lymphoblastic leukemia Blood 99 2002 3367 3375 (Pubitemid 34525318)
40. K.M. Ahmed, D. Nantajit, M. Fan, J.S. Murley, D.J. Grdina, and J.J. Li Coactivation of ATM/ERK/NF-kappaB in the low-dose radiation-induced radioadaptive response in human skin keratinocytes Free Radic Biol Med 46 2009 1543 1550
41. P.A. Leighton, J.R. Saam, R.S. Ingram, C.L. Stewart, and S.M. Tilghman An enhancer deletion affects both H19 and Igf2 expression Genes Dev 9 1995 2079 2089
42. S. Runge, F.C. Nielsen, J. Nielsen, J. Lykke-Andersen, U.M. Wewer, and J. Christiansen H19 RNA binds four molecules of insulin-like growth factor II mRNA-binding protein J Biol Chem 275 2000 29562 29569 (Pubitemid 32043834)
43. C.I. Brannan, E.C. Dees, R.S. Ingram, and S.M. Tilghman The product of the H19 gene may function as an RNA Mol Cell Biol 10 1990 28 36
44. W. Reik, and J. Walter Genomic imprinting: parental influence on the genome Nat Rev Genet 2 2001 21 32 (Pubitemid 33674766)
45. R. Ohlsson, F. Hedborg, L. Holmgren, C. Walsh, and T.J. Ekstrom Overlapping patterns of IGF2 and H19 expression during human development: biallelic IGF2 expression correlates with a lack of H19 expression Development 120 1994 361 368 (Pubitemid 24042403)
46. X. Li, Z. Nong, C. Ekstrom, E. Larsson, H. Nordlinder, and W.J. Hofmann Disrupted IGF2 promoter control by silencing of promoter P1 in human hepatocellular carcinoma Cancer Res 57 1997 2048 2054 (Pubitemid 27209740)
47. I. Ariel, S. Ayesh, E.J. Perlman, G. Pizov, V. Tanos, and T. Schneider The product of the imprinted H19 gene is an oncofetal RNA Mol Pathol 50 1997 34 44
48. A.P. Feinberg, and B. Vogelstein Hypomethylation of ras oncogenes in primary human cancers Biochem Biophys Res Commun 111 1983 47 54 (Pubitemid 13125134)
49. M. Halonen, M. Pelto-Huikko, P. Eskelin, L. Peltonen, I. Ulmanen, and M. Kolmer Subcellular location and expression pattern of autoimmune regulator (Aire), the mouse orthologue for human gene defective in autoimmune polyendocrinopathy candidiasis ectodermal dystrophy J Histochem Cytochem 49 2001 197 208 (Pubitemid 32113382)